April 14th 2025
The survey included responses from over one thousand medical cannabis patients, plus an analysis of trends in the medical cannabis market.
Neuropathix, Inc.’s CBD Chemotherapy Study Published in British Journal of Pharmacology
May 24th 2021British Journal of Pharmacology published a study' findings that highlighted the ability of Neuropathix’s patented compound KLS-13019 to prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in mice.
Cannabis as the Go-To Therapeutic: One Family’s Personal Journey of Discovery
April 30th 2021Brendan McKernan and his father Richard found their way to medical cannabis almost as a last resort, but the plant became a turning point in their lives and careers that led to them down a road to help others.